API
< Back to all clusters
[HEALTH] · Portugal · 3 sources

started · updated

Researchers in Portugal advance cancer study research

Medical researchers in Portugal are pursuing different approaches to understanding and treating cancer progression.

At the University of Lisbon, João Forjaz de Lacerda, a professor and researcher at ULS Santa Maria and the Gulbenkian Institute of Molecular Medicine, is working to develop cells capable of recognizing a specific marker. This marker is expressed due to the process of malignancy itself, rather than being specific to a single type of blood cancer cell, potentially allowing for a broader therapeutic approach.

Separately, a team from the Institute for Research and Innovation in Health (i3S) at the University of Porto has identified a mechanism related to the early stages of breast cancer growth. Their study, published in the Journal of Cell Biology, reveals that instead of losing connections, pre-cancerous cells initially strengthen their bonds with one another. This increase in mechanical tension triggers signals that stimulate cell proliferation and promote tumor growth.

Entities

Gulbenkian Institute of Molecular Medicine · Institute for Research and Innovation in Health · João Forjaz de Lacerda · University of Lisbon · University of Porto